Early research (Phase 1)Study completedNCT04818632What this trial is testingAZD9833 China PK StudyWho this might be right forER+, HER2-, Metastatic Breast Cancer AstraZeneca 28
Testing effectiveness (Phase 2)Study completedNCT00767520What this trial is testingSafety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast CancerWho this might be right forBreast Cancer Bristol-Myers Squibb 155
Early research (Phase 1)Active Not RecruitingNCT05870579What this trial is testing[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02238808What this trial is testingSee Whether Estrogen Can Slow the Growth of Some ER Positive Breast CancersWho this might be right forEstrogen Receptor Positive Breast Cancer AHS Cancer Control Alberta 19
Testing effectiveness (Phase 2)Ended earlyNCT01776008What this trial is testingAkt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerWho this might be right forEstrogen Receptor PositiveHER2/Neu NegativeRecurrent Breast Carcinoma+5 more National Cancer Institute (NCI) 16
Very early researchEnded earlyNCT00651976What this trial is testingLetrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryWho this might be right forBreast Cancer Vanderbilt-Ingram Cancer Center 213
Early research (Phase 1)Ended earlyNCT03596658What this trial is testingSHR9549 in ER Positive HER2 Negative Advanced Breast CancerWho this might be right forER+ HER2- Advanced Breast Cancer Jiangsu HengRui Medicine Co., Ltd. 4
Not applicableEnded earlyNCT05560685What this trial is testingSMART-ER: Symptom Monitoring With Patient-reported OutcomesWho this might be right forBreast Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Testing effectiveness (Phase 2)Study completedNCT00871858What this trial is testingAnastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast CancerWho this might be right forBreast Cancer Institut Bergonié 120
Not applicableActive Not RecruitingNCT04597580What this trial is testingPersonalised Disease Monitoring in Metastatic Breast CancerWho this might be right forBreast Cancer MetastaticEstrogen Receptor-positive Breast Cancer The Christie NHS Foundation Trust 97
Testing effectiveness (Phase 2)Study completedNCT01160718What this trial is testingFulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor TherapyWho this might be right forBreast Cancer Swiss Cancer Institute 46
Not applicableUnknownNCT03768479What this trial is testingThe Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerFulvestrant First Affiliated Hospital Xi'an Jiaotong University 68
Testing effectiveness (Phase 2)Study completedNCT00365599What this trial is testingPhase II Trial of SAHA & Tamoxifen for Patients With Breast CancerWho this might be right forBreast Cancer H. Lee Moffitt Cancer Center and Research Institute 43
Large-scale testing (Phase 3)Looking for participantsNCT06757634What this trial is testingPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)Who this might be right forBreast Cancer Celcuity Inc 1,180
Testing effectiveness (Phase 2)Study completedNCT01589367What this trial is testingNeoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast CancerWho this might be right forHormone Receptor Positive Malignant Neoplasm of Breast Seoul National University Hospital 208
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590857What this trial is testingTrial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.Who this might be right forMetastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more RayzeBio, Inc. 16
Early research (Phase 1)Ended earlyNCT03128619What this trial is testingCopanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerWho this might be right forEstrogen Receptor PositiveHER2/Neu NegativeInvasive Breast Carcinoma+14 more Jonsson Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400What this trial is testingLearn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsWho this might be right forBreast CancerSolid Tumors Pfizer 235
Large-scale testing (Phase 3)Looking for participantsNCT07647328What this trial is testingA Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerWho this might be right forER-Positive HER2-Negative Breast Cancer AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT02730429What this trial is testingTrial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial CancerWho this might be right forEndometrial Cancer Nordic Society of Gynaecological Oncology - Clinical Trials Unit 78